20/06/2024 Healthcare
Nixmino 7% Injection combines amino acids infusion with malic acid to address renal insufficiency. This formulation supports renal function by providing essential amino acids necessary for protein synthesis and tissue repair. Malic acid enhances cellular energy production, aiding in metabolic processes crucial for kidney health. Administered intravenously, Nixmino 7% Injection is designed to supplement renal function, offering therapeutic support in managing conditions associated with renal insufficiency. Available in PCD Franchise for injectable range and third party manufacturing.
Biopolis Lifesciences offers a PCD pharma franchise monopoly basis to help you grow your business with exclusive rights in your region. Our monopoly b...
Start your journey with Biopolis Lifesciences is a trusted general range PCD company delivering profitable business opportunities in India. We special...
We offer a profitable opportunity in the PCD pharma franchise company sector. Along with that we deliver a comprehensive range of high-quality product...
Biopolis Lifesciences is one of the trusted PCD pharma franchise company known for providing quality, innovation and profitable opportunities. We help...
More Details